1H HR-MAS NMR Based Metabolic Profiling of Cells in Response to Treatment with a Hexacationic Ruthenium Metallaprism as Potential Anticancer Drug.

PLoS One · 2015 · PMC4449131 · PMID 26024484

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

In HEK-293 cells following 24 h drug incubation an overall trend towards increased lipids, significant for the unsaturated lipid resonances after Bonferroni correction, could be observed possibly reflecting an early stage of apoptosis.

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.